Agmatine for Health & Longevity - Quick Reference Sheet

Agmatine for Health & Longevity

Created on 07/25/2026 – Quick Reference based on Evidence Review created using AI4L / Opus 4.8 Audit

Agmatine is an inexpensive molecule made from the amino acid arginine that acts on many nerve and blood-vessel systems at once. Its most credible human benefit is short-term relief of nerve-related and disc pain; claims for mood, brain protection, exercise blood flow, metabolism, and longevity rest mainly on animal studies. Short courses seem well tolerated, but long-term safety is unknown. (Full Review)

Protocol

Clinical Dose
2.67 g/day
Best-documented regimen; ~2-week course for lumbar disc nerve pain
Supplemental Dose
500–1,500 mg/day
Typical in nootropic and fitness use
Dosing Pattern
Split 2–3× daily
With food; single pre-workout dose only for acute blood-flow use
Time to effect
Pain Relief
Days–2 weeks
With consistent daily use
Mood
Days–2 weeks
Case-report evidence only
Exercise Pump
Within 1 hour
Acute, per-dose effect

Benefits

Contraindications
  • Pregnancy and breastfeeding
  • Women of reproductive age trying to conceive
  • Significant chronic kidney disease
  • Uncontrolled or labile blood pressure
  • Children
  • Multiple interacting medications without clinical oversight
Key Interactions
  • Blood-pressure medications (alpha-2 agonists, calcium-channel blockers, ACE inhibitors)
  • Other nitric-oxide and blood-flow supplements (L-Arginine, L-Citrulline, beetroot/nitrate, PDE5 inhibitors)
  • NMDA-receptor drugs (ketamine, memantine, dextromethorphan)
  • Opioid analgesics
  • Antidiabetic drugs (metformin, sulfonylureas, insulin)
  • Over-the-counter agents (decongestants, high-dose caffeine, NSAIDs)

Risk & Side Effects

  • High:
  • Medium: Gastrointestinal disturbances
  • Low: Unpredictable blood pressure and cardiovascular changes; unknown long-term safety profile
  • Speculative: Effects on pregnancy and hormonal signaling; interaction with histamine clearance

Monitoring

Marker Target Why
Blood pressure ~110–125 / 70–80 mmHg Can be raised or lowered unpredictably
Resting heart rate 55–70 bpm Cardiovascular effects can alter heart rate
eGFR >90 mL/min/1.73 m² Agmatine is cleared by the kidneys
Fasting glucose 75–90 mg/dL Imidazoline effects may influence glucose
BUN 10–18 mg/dL Complements eGFR for renal status

Cadence: Blood pressure and heart rate several times weekly during weeks 1–4; kidney function and fasting glucose at ~3 months, then every 6–12 months for sustained use

Qualitative Assessment

  • Pain intensity and interference with daily activities
  • Mood, anxiety, and stress resilience
  • Perceived workout blood flow, "pump," and exercise tolerance
  • Sleep quality and daytime energy
  • Any digestive symptoms signaling the dose is too high